Breast Cancer Screening and Management (BCSM) Clinical Decision Support (CDS) Implementation Guide
1.0.0 - ci-build

Breast Cancer Screening and Management (BCSM) Clinical Decision Support (CDS) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: Special Populations (Experimental)

Official URL: http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-SpecialPopulations Version: 1.0.0
Draft as of 2024-10-22 Computable Name: flow-SpecialPopulations

Copyright/Legal: (C) 2024 The MITRE Corporation. All Rights Reserved. Approved for Public Release: 24-2711. Distribution Unlimited. Unless otherwise noted, this work is available under an Apache 2.0 license. It was produced by the MITRE Corporation for the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention in accordance with the Statement of Work, contract number 75FCMC18D0047, task order number 75D30123F17931.

Patient population that have been identified as higher than average risk or otherwise requiring specific consideration within a particular guideline.

Provides criteria to determine age to start, screening modality, and screening interval for these populations of patients.

Id: flow-SpecialPopulations
Url: Special Populations
Version: 1.0.0
Title: Special Populations
Status: draft
Experimental: true
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2024-10-22
Publisher: MITRE
Description:

Patient population that have been identified as higher than average risk or otherwise requiring specific consideration within a particular guideline.

Provides criteria to determine age to start, screening modality, and screening interval for these populations of patients.
Knowledge Capability: executable
Knowledge Representation Level: structured
Copyright:

(C) 2024 The MITRE Corporation. All Rights Reserved. Approved for Public Release: 24-2711. Distribution Unlimited. Unless otherwise noted, this work is available under an Apache 2.0 license. It was produced by the MITRE Corporation for the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention in accordance with the Statement of Work, contract number 75FCMC18D0047, task order number 75D30123F17931.
Approval Date: 2024-10-22
Libraries:
Library/SpecialPopulations|1.0.0
Actions:
Annual screening mammogram starting age 30: An annual screening mammogram starting at age 30 is recommended. Women who are at higher than average risk for breast cancer based on certain risk factors should get a mammogram every year, typically starting at age 30.
If: Applicability: (ExistsACSMammoHighRisk)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
%action.code[0].coding[0]: (ACSMammoHighRiskCode)
%action.timingTiming: (ACSMammoHighRiskTiming)
%action.extension: (ACSMammoHighRiskFlag)
code.coding[0]: (ACSMammoHighRiskCode)
reasonCode[0].coding[0]: (ACSMammoHighRiskReason)
occurrenceDateTime: (ACSMammoHighRiskTimingEvent)
Annual screening MRI starting age 30: An annual screening MRI starting at age 30 is recommended. Women who are at higher than average risk for breast cancer based on certain risk factors should get a breast MRI every year, typically starting at age 30.
If: Applicability: (ExistsACSMriHighRisk)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
%action.code[0].coding[0]: (ACSMriHighRiskCode)
%action.timingTiming: (ACSMriHighRiskTiming)
%action.extension: (ACSMriHighRiskFlag)
code.coding[0]: (ACSMriHighRiskCode)
reasonCode[0].coding[0]: (ACSMriHighRiskReason)
occurrenceDateTime: (ACSMriHighRiskTimingEvent)
Annual screening mammo starting age 30: An annual screening mammogram starting at age 30 is recommended. Women who are at higher than average risk for breast cancer based on certain risk factors should get a mammogram every year, typically starting at age 30.
If: Applicability: (ExistsACSFirstDegGeneticMammo)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
%action.code[0].coding[0]: (ACSFirstDegGeneticMammoCode)
%action.timingTiming: (ACSFirstDegGeneticMammoTiming)
%action.extension: (ACSFirstDegGeneticMammoFlag)
code.coding[0]: (ACSFirstDegGeneticMammoCode)
reasonCode[0].coding[0]: (ACSFirstDegGeneticMammoReason)
occurrenceDateTime: (ACSFirstDegGeneticMammoTimingEvent)
Annual screening MRI starting age 30: An annual screening MRI starting at age 30 is recommended. Women who are at higher than average risk for breast cancer based on certain risk factors should get a breast MRI every year, typically starting at age 30.
If: Applicability: (ExistsACSFirstDegGeneticMri)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
%action.code[0].coding[0]: (ACSFirstDegGeneticMriCode)
%action.timingTiming: (ACSFirstDegGeneticMriTiming)
%action.extension: (ACSFirstDegGeneticMriFlag)
code.coding[0]: (ACSFirstDegGeneticMriCode)
reasonCode[0].coding[0]: (ACSFirstDegGeneticMriReason)
occurrenceDateTime: (ACSFirstDegGeneticMriTimingEvent)
Perform lifetime risk assessment: Consider performing assessment of lifetime risk, as defined by models largely dependent on family history. If estimated lifetime risk is >20%, based on informal assessment or assessment using validated risk model, then patient is eligible for annual screening mammogram starting at age 30 and supplemental screening with annual screening MRI. Otherwise, patient can be offered annual screening mammogram starting at age 40. Validated tools include BRCAPRO, Claus, BOADICEA [Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm], and Tyrer-Cuzick.
If: Applicability: (ExistsBreastImagingHeterogenouslyOrExtremelyDense)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
reasonCode[0].coding[0]: (BreastImagingHeterogenouslyOrExtremelyDenseReason)
Perform lifetime risk assessment: Consider performing assessment of lifetime risk, as defined by models largely dependent on family history. If estimated lifetime risk is >20%, based on informal assessment or assessment using validated risk model, then patient is eligible for annual screening mammogram starting at age 30 and supplemental screening with annual screening MRI. Otherwise, patient can be offered annual screening mammogram starting at age 40. Validated tools include BRCAPRO, Claus, BOADICEA [Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm], and Tyrer-Cuzick.
If: Applicability: (ExistsCompellingFamilyHistory)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
%action.code[0].coding[0]: (CompellingFamilyHistoryCode)
code.coding[0]: (CompellingFamilyHistoryCode)
reasonCode[0].coding[0]: (CompellingFamilyHistoryReason)
Biennial screening mammo starting age 40: Biennial screening mammogram starting at age 40
If: Applicability: (ExistsUSPSTFRecommendation)
Then: Definition: http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/BreastCancerScreeningServiceRequest|1.0.0
Dynamic Values:
%action.code[0].coding[0]: (USPSTFRecommendationCode)
%action.timingTiming: (USPSTFRecommendationTiming)
%action.extension: (USPSTFRecommendationFlag)
code.coding[0]: (USPSTFRecommendationCode)
reasonCode[0].coding[0]: (USPSTFRecommendationReason)
occurrenceDateTime: (USPSTFRecommendationTimingEvent)

Notes: